Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization

• Conditions: Vaccination

• Registration Number: NCT04869735
• Lead Sponsor: Université de Reims Champagne-Ardenne

Brief Summary

The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio.

In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended.

The vaccination coverage for patients over 16 years of age is insufficient in France.

Detailed Description

The aim of the study is to evaluate impact of information about booster vaccination against DTPolio at 25 years on this booster vaccination's realization.

Study Timeline

• Status Verified: 2021-04
• Study First Submitted: 2021-04-27
• Study First Submitted QC: 2021-04-27
• Study First Posted: 2021-05-03
• Study Start: 2021-06-04
• Last Update Submitted: 2021-07-01
• Last Update Posted: 2021-07-06
• Primary Completion: 2022-06-01
• Study Completion: 2022-09-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2125

Inclusion Criteria

• aged 25 years old in 2020
• without delivery of DTPolio vaccine in 2019 or 2020

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DTPolio vaccine delivery	12 months	DTPolio vaccine delivery by pharmacies within 12 months of sending information about booster vaccination against DTPolio at 25 years

Trial Locations

Locations (1)

Université de Reims Champagne-Ardenne; 🇫🇷 Reims, France